Alan Maynard, Trevor Sheldon. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisState Medicine/economicsState Medicine/organization & administrationUnited Kingdom
Year: 2002 PMID: 12241698 DOI: 10.1016/S0140-6736(02)09736-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321